• HOME
  • BUSINESS
  • MARKETS
  • BIOTECH
  • LIFESTYLE
  • TRENDING
Search
Financial Trends
  • HOME
  • BUSINESS
  • MARKETS
  • BIOTECH
  • LIFESTYLE
  • TRENDING

Tag: NASDAQ:SNSS

Business

FDA Says No To Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Cancer Drug

Aaron Lyons -
Health

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)’s Late-Breaking Presentation, Conference Call and Research Publications

Brandon Manns -




  • Contact Us
  • Authors
  • Privacy Policy
  • Terms of Use
  • Copyright & Content License
  • Reprint Licensing
  • About Us
  • Disclaimer
  • DISCLAIMER
© Copyright 2018 - Financials Trend